Skip to content

Clinical trials

Phase 2 trials in Hong Kong with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Unknown status Country / region: Hong Kong Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20163
20176
20184
20207
20214
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong22
Chinese University of Hong Kong3
National University Hospital, Singapore3
Bio-Cancer Treatment International Limited1
Dr Joanne CHIU1
Ivan FN Hung MD1
Matrix Pharmaceutical1
TJ Biopharma Co., Ltd.1
The Hong Kong Polytechnic University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-195
Leukemia, Myeloid, Acute4
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Hepatocellular2
Dental Caries2
Primary Myelofibrosis2
Anosmia1
Congenital Microtia1
Dentofacial Deformities1
Esophageal Achalasia1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.